Kupara, Dorothy ORCID: https://orcid.org/0009-0000-3583-269X (2025) Minimising polypharmacy to enhance care and outcomes for people with learning disabilities. Learning Disability Practice. ISSN 1465-8712

PDF/A KuparaD_Evidence & practice CPD Polypharmacy in people with learning disabilities_AM_PDFA.pdf - Accepted Version Restricted to Repository staff only Available under License Creative Commons Attribution Non-commercial. Download (275kB) | Request a copy

Abstract

People with learning disabilities often require medicines for various comorbidities. However, limited understanding of this population among healthcare professionals can contribute to high rates of overprescription and polypharmacy, which may adversely affect people’s health and quality of life. While polypharmacy may be appropriate and necessary in many cases, effective medicines management is essential. This article explores the challenges in relation to medicines experienced by many people with learning disabilities, family members, carers and healthcare professionals. It also discusses the vital role of the multidisciplinary team in reducing overprescription, optimising medicines use and promoting shared decision-making to enhance health outcomes.

Item Type:	Article
Identifier:	https://doi.org/ 10.7748/ldp.2026.e2288
Additional Information:	This is an Accepted Manuscript of an article published by RCNi in Learning Disability Practice on 19 March 2026, available online: http://doi.org/10.7748/ldp.2026.e2288
Keywords:	polypharmacy, multiple medications, comorbidities, medicine optimisation,
Date Deposited:	01 Apr 2026
URI:	https://repository.uwl.ac.uk/id/eprint/14811
Sustainable Development Goals:	Goal 10: Reduced Inequalities

Actions (admin access)